Postsurgical complication risk seen in IBD patients taking anti-TNF drugs

05/6/2013 | Medscape (free registration)

Patients who take drugs that block tumor necrosis factor alpha have a slightly higher risk of complications following surgery to treat inflammatory bowel disease, Canadian researchers reported. Dr. John Marshall of McMaster University said the study should not change physician practice, but should serve as a caution to doctors and patients that they must weigh all the risks and benefits of surgery for IBD.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA